Postprandial Lipid Metabolism in Normolipidemic Subjects and Patients with Mild to Moderate Hypertriglyceridemia: Effects of Test Meals Containing Saturated Fatty Acids, Mono-Unsaturated Fatty Acids, or Medium-Chain Fatty Acids

A placebo‐controlled proof‐of‐concept study of alirocumab on postprandial lipids and vascular elasticity in insulin‐treated patients with type 2 diabetes mellitus

(2020) Benjamin Burggraaf et al.   DIABETES OBESITY & METABOLISM

Association of Hypertriglyceridemia with All‐Cause Mortality and Atherosclerotic Cardiovascular Events in a Low‐Risk Italian Population: The TG‐REAL Retrospective Cohort Analysis

(2020) Marcello Arca et al.   Journal of the American Heart Association

Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease

(2019) Brian A. Ference et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Clinical review on triglycerides

(2019) Ulrich Laufs et al.   EUROPEAN HEART JOURNAL

The diagnosis and treatment of hypertriglyceridemia

(2019) Klaus G. Parhofer et al.   Deutsches Arzteblatt International

The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk

(2018) Pratik B Sandesara et al.   ENDOCRINE REVIEWS

Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled crossover trial

(2017) Charlotte Koopal et al.   JOURNAL OF LIPID RESEARCH

A Test in Context: Lipid Profile, Fasting Versus Nonfasting

(2017) Børge G. Nordestgaard   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics

(2017) Kjetil Retterstøl et al.   Lipids in Health and Disease

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

(2016) Børge G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Postprandial hyperlipidemia as a potential residual risk factor

(2016) Kazufumi Nakamura et al.   Journal of Cardiology

Extended-Release Niacin/Laropiprant Improves Overall Efficacy of Postprandial Reverse Cholesterol TransportSignificance

(2015) Petra El Khoury et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Mendelian randomization of blood lipids for coronary heart disease

(2014) Michael V. Holmes et al.   EUROPEAN HEART JOURNAL

The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis

(2012) M Hassan Murad et al.   BMC Endocrine Disorders

Postprandial lipemia and cardiovascular disease risk: Interrelationships between dietary, physiological and genetic determinants

(2011) Kim G. Jackson et al.   ATHEROSCLEROSIS

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

(2011)   NEW ENGLAND JOURNAL OF MEDICINE